DE2019570C2 - Water-soluble khellin derivative: 1H, 3H-2-aza-4-methylene-5,8-dimethoxy-furo (2 ", 3", 6,7) xanthone-2-spiro-1'-piperidinium chloride and process for its preparation - Google Patents
Water-soluble khellin derivative: 1H, 3H-2-aza-4-methylene-5,8-dimethoxy-furo (2 ", 3", 6,7) xanthone-2-spiro-1'-piperidinium chloride and process for its preparationInfo
- Publication number
- DE2019570C2 DE2019570C2 DE19702019570 DE2019570A DE2019570C2 DE 2019570 C2 DE2019570 C2 DE 2019570C2 DE 19702019570 DE19702019570 DE 19702019570 DE 2019570 A DE2019570 A DE 2019570A DE 2019570 C2 DE2019570 C2 DE 2019570C2
- Authority
- DE
- Germany
- Prior art keywords
- khellin
- water
- soluble
- xanthone
- aza
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Description
Cle Cl e
H3CO OH 3 CO O
HClHCl
-1O- 1 O
durch Umsetzen von Khellin mit Piperidin und überschüssigem Parafönrialdehyd in Gegenwart eines Lösungsmittels, dadurch gekennzeichnet, daß man die Umsetzung in einem Gemisch aus 50 Volumenteilen Benzol und 37 Volumenteilen Nitrobenzol unter Sieden am Wasserabscheider zunächst unter Verwendung einer äquimolekularen Menge Paraformaldehyd durchführt und weitere äquimolekularen Mengen Paraformaldehyd im Abstand von 2, 4 und 6 Stunden nach Beginn der Umsetzung zusetzt.by reacting khellin with piperidine and excess Parafonrialdehyde in the presence of a Solvent, characterized in that the reaction is carried out in a mixture 50 parts by volume of benzene and 37 parts by volume of nitrobenzene with boiling on the water separator initially using an equimolecular amount of paraformaldehyde and others equimolecular amounts of paraformaldehyde at intervals of 2, 4 and 6 hours after the start of the reaction clogs.
zugeschrieben.attributed to.
In keinem Falle wurden, wie durch wiederholtes Nacharbeiten festgestellt wurde, Ausbeuten über 25%
d. Th. erzielt
Es wurde nunmehr durch eingehende Untersuchung erkannt, daß diese spasmolytisch und blutdrucksenkend
wirkende Verbindung in Wirklichkeit das 1-H3H-2-Aza-4-methylen-5,8-di-methoxyfuro(2",3",6/;-xanthon-2-spiro-r-piperidiniumchlorid
ist und die folgende Strukturformel besitzt:In no case were, as was found by repeated reworking, yields above 25% of theory. Th. Achieved
It has now been recognized through detailed investigation that this spasmolytic and antihypertensive compound is in fact 1-H3H-2-aza-4-methylene-5,8-dimethoxyfuro (2 ", 3", 6 /; - xanthone- 2-spiro-r-piperidinium chloride and has the following structural formula:
2020th
H3COH 3 CO
H3COH 3 CO
Cle Cl e
Khellin, der Dimethyläther
thy!4',5': 6,7-furanochromons (I)Khellin, the dimethyl ether
thy! 4 ', 5': 6,7-furanochromons (I)
H3COH 3 CO
CH3 CH 3
des 5,8-Dioxy-2-me-des 5,8-dioxy-2-me-
OCH3 OCH 3
nimmt unter den Asthmamitteln wegen seiner coronarerweiternden und spasmolytischen Eigenschaften eine bevorzugte Stellung ein. Der parenteralen Anwendung dieses Stoffes steht seine schwere Löslichkeit entgegen.takes one of the asthma drugs because of its coronary-dilating and spasmolytic properties preferred position. The parenteral use of this substance stands in the way of its poor solubility.
Es hat nicht an Versuchen gefehlt, durch Anwendung vo»i Lösungsvermittlern — z. B. Theophyllinderivaten — Khellin in Lösung zu bringen und damit für Injektionszwecke brauchbar zu machen. Weiterhin ist versucht worden, durch Umwandlung des Khellins zu wasserlöslichen Substanzen zu kommen, die bei gleicher pharmakologischer Wirksamkeit eine parenterale Applikation ermöglichen.There has been no lack of attempts to use solubilizers - e.g. B. theophylline derivatives - Bringing khellin into solution and thus making it usable for injection purposes. Attempts are still being made have been to come to water-soluble substances by converting the khellin, which with the same pharmacological effectiveness enable parenteral administration.
Es ist bekannt, Khellin in Lösungsmitteln einer Mannich-Aminomethylierung durch Umsetzen mit Piperidin und Formaldehyd oder Paraformaldehyd zu unterwerfen. Gemäß der deutschen Patentschrift 11 97 454 wird die Reaktion in Gegenwart von Eisessig oder Dioxan als Lösungsmittel und gemäß der deutschen Patentschrift 12 Ol 840 in Gegenwart größerer Mengen Wasser sowie Nitrobenzol und Benzol durchgeführt. Dem dabei isolierten wasserlöslichen Derivat wurde folgende For-Es wurde nun gefunden, daß man zu diesen wasserlöslichen Khellinderivaten in verbesserter Ausbeute dadurch gelangt, daß man die Umsetzung in einem Gemisch aus 50 Volumenteilen Benzol und 37 Volumenteilen Nitrobenzol unter Sieden am Wasserabscheider zunächst unter Verwendung einer äquimolekularen Menge Paraformaldehyd durchführt und weitere äquimolekulare Mengen Paraformaldehyd im Abstand von 2, 4 und 6 Stunden nach Beginn der Umsetzung zusetzt.It is known that khellin in solvents of a Mannich aminomethylation by reacting with piperidine and formaldehyde or paraformaldehyde. According to German Patent 11 97 454, the reaction in the presence of glacial acetic acid or dioxane is as Solvent and according to German Patent 12 Ol 840 in the presence of large amounts of water as well Nitrobenzene and benzene carried out. The following formula was assigned to the water-soluble derivative isolated in this way it has now been found that these water-soluble khellin derivatives can be obtained in an improved yield reaches that the reaction is carried out in a mixture of 50 parts by volume of benzene and 37 parts by volume Nitrobenzene boiling on a water separator initially using an equimolecular amount Paraformaldehyde carries out and further equimolecular amounts of paraformaldehyde at intervals of 2, 4 and added 6 hours after the start of the reaction.
26,0 g Khellin, 12,16 g Piperidin-hydrochlorid und 3.0 g Paraformaldehyd werden in einem Lösungsmittelgemisch aus 50 ml Benzol und 37 ml Nitrobenzol suspendiert und am Wasserabscheider zum Sieden erhitzt. Nach 2, 4 und 6 Stunden werden jeweils weitere 3,0 g Paraformaldehyd hinzugesetzt. Nach 8 Stunden wird der entstandene gelbe, kristalline Niederschlag heiß abgesaugt, mit wenig Benzol nachgewaschen und über26.0 g of khellin, 12.16 g of piperidine hydrochloride and 3.0 g of paraformaldehyde are added to a solvent mixture suspended from 50 ml of benzene and 37 ml of nitrobenzene and heated to the boil on a water separator. After 2, 4 and 6 hours, a further 3.0 g of paraformaldehyde are added in each case. After 8 hours it will the resulting yellow, crystalline precipitate is suctioned hot, washed with a little benzene and over
so Nacht getrockn-st. Das Rohprodukt wird mit wenig heißem Benzol ausgekocht, abgesaugt, mit wenig heißem • Benzol nachgewaschen und getrocknet. Das von Khellinresten befreite Reaktionsprodukt wird aus absolutem Äthanol umkristallisiert.so night dried-st. The crude product is hot with little Boiled benzene, vacuumed off, washed with a little hot • benzene and dried. That from The reaction product freed from residues of khellin is recrystallized from absolute ethanol.
Gelbe Kristalle, F. 265° C
Ausbeute: 45% d. Th.Yellow crystals, m.p. 265 ° C
Yield: 45% of theory Th.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19702019570 DE2019570C2 (en) | 1970-04-23 | 1970-04-23 | Water-soluble khellin derivative: 1H, 3H-2-aza-4-methylene-5,8-dimethoxy-furo (2 ", 3", 6,7) xanthone-2-spiro-1'-piperidinium chloride and process for its preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19702019570 DE2019570C2 (en) | 1970-04-23 | 1970-04-23 | Water-soluble khellin derivative: 1H, 3H-2-aza-4-methylene-5,8-dimethoxy-furo (2 ", 3", 6,7) xanthone-2-spiro-1'-piperidinium chloride and process for its preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
DE2019570A1 DE2019570A1 (en) | 1971-11-11 |
DE2019570C2 true DE2019570C2 (en) | 1984-05-30 |
Family
ID=5768916
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19702019570 Expired DE2019570C2 (en) | 1970-04-23 | 1970-04-23 | Water-soluble khellin derivative: 1H, 3H-2-aza-4-methylene-5,8-dimethoxy-furo (2 ", 3", 6,7) xanthone-2-spiro-1'-piperidinium chloride and process for its preparation |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE2019570C2 (en) |
-
1970
- 1970-04-23 DE DE19702019570 patent/DE2019570C2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DE2019570A1 (en) | 1971-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE1420015B1 (en) | 2'-Hydroxy-5,9-dimethyl-6,7-benzomorphane | |
DE1695753A1 (en) | Improvements in the preparation of 4-oxopiperidine compounds and certain new 4-oxopiperidine compounds | |
DE1180372B (en) | Process for the preparation of 2,6-dioxopiperazines | |
DE2458638C2 (en) | 4'-substituted 2-methyl-3-piperidinopropiophenone derivatives, processes for their production and pharmacological preparations which contain them | |
DE2019570C2 (en) | Water-soluble khellin derivative: 1H, 3H-2-aza-4-methylene-5,8-dimethoxy-furo (2 ", 3", 6,7) xanthone-2-spiro-1'-piperidinium chloride and process for its preparation | |
DE1912941C3 (en) | 1-phenyl ^ -amino-e-methoxypyridazinium salts | |
DE1212984B (en) | Process for the production of basic substituted coumarones | |
DE2845857A1 (en) | BENZO SQUARE CLIP ON SQUARE CLIP ON THIAZOLE DERIVATIVES, THE PROCESS FOR THEIR MANUFACTURING AND THE MEDICINAL PREPARATIONS CONTAINING THEM | |
DE2436721A1 (en) | 2,2-DISUBSTITUTED BENZODIOXOL ETHERS | |
DE2501220C3 (en) | Process for the preparation of substituted 1,7-diphenyl-5-hydroxyhepta- (1,4,6) -trien- (3) -ones | |
DE2246428C3 (en) | ||
CH605922A5 (en) | Quinazolines prepn. | |
AT223324B (en) | Process for the preparation of nitriles of the tetracyclines | |
DE1695021C (en) | Process for the preparation of 2H isoquinones without thione derivatives | |
DE1445760C (en) | Substituted 1 square bracket on thiazolyl (2) square bracket to hexahydro s tnazin 2 one and thione | |
DE663543C (en) | Process for the production of Abkoemmlingen the pyrazine monocarboxylic acid | |
DE2345651A1 (en) | INDOLYL ALKYLAMINES AND THE PROCESS FOR THEIR PRODUCTION | |
DE933272C (en) | Process for the preparation of 5-thione-3-oxyphenyl-1,2-dithiols or their sulfonium compounds | |
DE1921340C3 (en) | 2-Phenyl-5-halo-pyrimidines substituted in the 4-position | |
AT269886B (en) | Process for the production of new benzomorphan derivatives and their salts | |
DE1768787C3 (en) | (o-Carboxy-phenyl) -acetamidine, process for their preparation and (o-CarboxyphenyO-acetamidine-containing preparations | |
AT253509B (en) | Process for the preparation of new piperidine carboxylic acid esters | |
DE2355917A1 (en) | PROCESS FOR THE PRODUCTION OF HIGHLY PURE 1.3-BIS- (BETA-AETHYLHEXYL) -5-AMINO- 5-METHYL-HEXAHYDROPYRIMIDINE | |
DE1060375B (en) | Process for the preparation of cyclic aldehydes | |
DE1051858B (en) | Process for the production of pellets of phenthiazine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
D2 | Grant after examination | ||
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |